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Abstract
Background: Limited data are available on smoking-related mortality in low-income countries, where both chronic disease
burden and prevalence of smoking are increasing.
Methods: Using data on 20, 033 individuals in the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh, we
prospectively evaluated the association between tobacco smoking and all-cause, cancer, and cardiovascular disease
mortality during ,7.6 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and
their 95% confidence intervals (CIs) for deaths from all-cause, cancer, CVD, ischemic heart disease (IHD), and stroke, in
relation to status, duration, and intensity of cigarette/bidi and hookah smoking.
Results: Among men, cigarette/bidi smoking was positively associated with all-cause (HR 1.40, 95% CI 1.06 1.86) and cancer
mortality (HR 2.91, 1.24 6.80), and there was a dose-response relationship between increasing intensity of cigarette/bidi
consumption and increasing mortality. An elevated risk of death from ischemic heart disease (HR 1.87, 1.08 3.24) was
associated with current cigarette/bidi smoking. Among women, the corresponding HRs were 1.65 (95% CI 1.16 2.36) for all-
cause mortality and 2.69 (95% CI 1.20 6.01) for ischemic heart disease mortality. Similar associations were observed for
hookah smoking. There was a trend towards reduced risk for the mortality outcomes with older age at onset of cigarette/
bidi smoking and increasing years since quitting cigarette/bibi smoking among men. We estimated that cigarette/bidi
smoking accounted for about 25.0% of deaths in men and 7.6% in women.
Conclusions: Tobacco smoking was responsible for substantial proportion of premature deaths in the Bangladeshi
population, especially among men. Stringent measures of tobacco control and cessation are needed to reduce tobacco-
related deaths in Bangladesh.
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Introduction
Tobacco use is the leading cause of preventable death and
disease worldwide and is estimated to kill more than 5 million
people each year [1]. According to the World Health Organiza-
tion (WHO), if current trends continue, by 2030 tobacco use could
cause 8 million deaths annually, with more than 80% of these
deaths in low- and middle-income countries [2]. While smoking
prevalence has declined in many developed countries, it remains
high in others and is increasing in low- and middle-income
countries [3]. About 80% of the world’s smokers now live in low-
and middle- income countries. The shift of the tobacco epidemic
to the developing world will lead to unprecedented levels of disease
and early death in countries where population growth and the
potential for increased tobacco use are highest and where health-
care services are least available [2].
Cigarette smoking is the most well-known form of tobacco use.
Most studies of cigarette smoking and mortality were conducted in
Western populations and data are limited in Asian and South
Asian. Hookah is another tobacco product with its use rapidly
spreading in the United States and Europe [4]. It has been
indicated that compared to cigarette smoking, hookah smoke
contains 36 times the amount of nicotine and higher concentra-
tions of heavy metals [5,6]. The investigation of the effects of
hookah smoking on mortality is lacking in both Western and Asian
populations. The association between cigarette or hookah smoking
and mortality may differ from one population to another due to
differences in the experience of different stages of epidemiologic
transition, demographic profile, life expectancy, as well as
distribution of other genetic and environmental risk factors of
specific diseases that may interact with effect of smoking [7]. South
Asia, where more than half of the world’s poor population lives, is
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also the single largest area on the globe for production and
consumption of tobacco products. However, large prospective
epidemiologic studies assessing the extent to which smoking
characters are related to total and cause-specific mortality,
especially cardiovascular disease (CVD) mortality, are lacking.
Detailed estimates of smoking-disease association and smoking-
attributable mortality may also help target interventions. In the
present study, we examined the association of tobacco smoking
with all-cause, cancer, and CVD mortality using ,7.6 years of
follow-up data from a large prospective cohort study of individuals




The Health Effects of Arsenic Longitudinal Study (HEALS) is
an ongoing prospective, population-based cohort study in
Araihazar, Bangladesh [8]. Between October 2000 and May
2002, from a well-defined 25 km2 geographical area, we recruited
11,746 men and women (original cohort) who were 1) married (to
reduce loss to follow-up) and aged 18–75 years, 2) residents of the
study area for at least 5 years prior to recruitment, and 3) primarily
drinking water from a local well. During 2006–2008, HEALS was
expanded to include an additional 8,287 participants (expansion
cohort) following the same methodologies. The overall participa-
tion rate was 97%. The participation rate was estimated as the
proportion of subjects who agreed to participate among the
potential participants we invited to the study [8]. Demographic
and lifestyle data for both the original and expansion cohort
participants were collected using a standardized questionnaire.
Trained study physicians measured height and weight using a
locally manufactured tape measure and a Misaki (Okaka, Japan)
scale (calibrated weekly), respectively. Both height and weight were
measured three times at baseline and averaged [9]. Trained
clinicians measured blood pressure with an automatic sphygmo-
manometer [10,11]. Although the original aim of the study was to
investigate health effects of arsenic exposure, population-based
studies can be used to provide epidemiologic data on health effects
of smoking that may be more generalizable.
Follow-up in-person interviews at two-year intervals were
conducted by trained physicians following the same procedures
used in the baseline interview. Between the biennial follow-up
visits, passive follow-up is conducted, as participants with health
conditions would visit the field clinic which was established
exclusively for the cohort participants to receive medical diagnoses
and treatments [8], and the relevant data are collected. Informed
consent was obtained from study participants and the study
procedures were approved by the Ethical Committee of the
Bangladesh Medical Research Council and the Institutional
Review Boards of Columbia University and the University of
Chicago. The present study included follow up data from baseline
to October 9, 2011.
Assessment of Mortality
Details of the methods for the assessment of causes of death are
described elsewhere [9,12,13]. Briefly, we adapted a validated
verbal autopsy procedure, developed by the International Centre
for Diarrhea Disease Research, Bangladesh, in collaboration with
the WHO, to ascertain the causes of death. During the follow-up,
upon receipt of a death reported by family or neighbors, a study
physician and a trained social worker administered the verbal
autopsy form to the next of kin. Medical records and death
certificates were collected and reviewed monthly by an outcome
assessment committee, consisting of physicians and consulting
medical specialists. Causes of deaths were coded according to the
WHO classification [14] and the International Classification of
Diseases, 10th Revision (ICD-10) [15]. The International Centre
for Diarrhea Disease Research, Bangladesh has used this method
to ascertain causes of deaths since 1971 [16,17] and documented
an overall 95% specificity, with a 85% sensitivity for cancer deaths
and 85% sensitivity for deaths due to CVD [18].
Assessment of Tobacco Smoking Variables
At baseline, detailed information on smoking of tobacco
products was collected. Details of smoking cigarettes and bidis
(filterless locally produced cigarettes) were asked together,
including information on past or current use, duration of use,
age at start, number of sticks per day, and age at quitting. A
separate set of questions were asked for hookah smoking (tobacco
smoking using waterpipes). We observed a high correlation
between hookah and cigarette/bidi smoking, such that 98% of
the 2,005 ever smokers of hookah were ever smokers of cigarette/
bidi. Although cigarettes and bidis frequently are sold individually
in Bangladesh, we calculated ‘‘pack-years’’ (product of sticks of
cigarette/bidi per day and years of smoking, divides by 20) for ease
in comparison with other studies. Similarly, a ‘‘time-years’’ index
(product of times per day and years of smoking) was calculated for
hookah smoking.
Statistical Analyses
Person years of follow-up were calculated from baseline to the
date of death from any cause (for those who died) or to October 9,
2011, the date of last death observed in the follow-up at the time of
data analyses (for those who were alive). Cox proportional hazards
models were used to estimate hazard ratios (HRs) and their 95%
confidence intervals (CIs) for deaths from all-cause, cancer, CVD,
ischemic heart disease (IHD), and stroke, in relation to status,
duration, and intensity of cigarette/bidi and hookah smoking.
Survival curves for overall survival were graphed by cigarette/bidi
smoking status among men and women. We evaluated the effect of
age at starting cigarette/bidi smoking and time since quitting
smoking on mortality from all-cause, cancer, and IHD among men
only, as the data were limited in women. All the analyses were
stratified by sex, as the prevalence of smoking is different in men
and women. HRs were adjusted for baseline age (years), body mass
index (BMI; kg/m2), and educational attainment (years). Analyses
were done with additional adjustments of other potential
confounders such as betel quid chewing and arsenic exposure or
potential intermediate factors such as systolic blood pressure and
diabetes. Results were similar and therefore are not shown.
Additional analyses were conducted to control for cigarette/bidi
smoking in the analyses of hookah smoking, and vice versa.
However, almost all the hookah smokers (99.1%) were also
cigarette/bidi smokers in our study population, and therefore it
was not possible to estimate HRs associated with hookah smoking
among nonsmokers of cigarette/bidi or to assess additive
interaction between hookah and cigarette/bidi smoking. Addi-
tional stratification by age, education, BMI, and betel quid
chewing status did not suggest any subgroup-specific associations
(all P for interaction were .0.10) and therefore results are not
shown. We calculated the population attributable fraction (PAF)
for all-cause mortality associated with ever cigarette/bidi or
hookah smoking and smoking intensity using adjusted HRs
estimated from Cox proportional hazards models. PAF was
calculated as follows [19]:
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Where Pi is the proportion of all-cause deaths in the ith smoking
category and HRi is the adjusted hazard ratio associated with the
ith smoking category (relative to nonsmokers). All analyses were
done with the SPSS 19.0 software (SPSS Inc., Chicago, IL).
Results
We observed 151, 641 person years during an average of 7.6
years of follow-up. There were 734 deaths, of which 128 were
from cancers and 308 were from CVD, accounting for 60% of
mortality. Among the 308 deaths from CVD, 119 were from IHD
and 129 were from stroke. The underlying causes of death and
ICD-10 codes were shown in Table S1.
The prevalence of cigarette/bidi smoking among men rose with
age, from 47% among those between 17 and 29 years to 88%
among those over 50 years. The age-specific prevalence of
smoking among women rose from 0.4 to 22%. The pattern of
hookah smoking is similar as that of cigarette/bidi smoking,
although the age-specific prevalence is much lower among men
(Figure 1A). Interestingly, in both men and women, younger
smokers of cigarette/bidi started smoking at an earlier age, with
smokers aged 17–29 years starting smoking before age 18
(Figure 1B). The prevalence of cigarette/bidi smoking according
to other baseline characteristics is shown in Table 1. Among both
men and women, cigarette/bidi smoking was more common
among those without primary education or with a lower BMI than
among other participants. The prevalence of cigarette/bidi
smoking was higher among ever hookah smokers and ever
chewers of betel quid, compared with never hookah smokers
and never chewers among both men and women. Women who
had a higher systolic blood pressure were more likely to be ever
cigarette/bidi smokers whereas men who had a lower diastolic
blood pressure were more likely to be ever cigarette/bidi smokers.
In men, there was an increased risk of all-cause and cancer
mortality in ever, past, and current smokers of cigarette/bidi,
compared with never smokers (Table 2). For both all-cause and
cancer mortality, there was a highly significant trend of increasing
mortality with increasing intensity of tobacco consumption. Ever
smokers who had smoked cigarette/bidi more than 10 sticks per
day, had smoked for more than 20 years, or had accumulated
Figure 1. Prevalence of smoking and age at starting smoking.
(A) Prevalence of cigarette/bidi smoking and hookah smoking by age
groups (17–29, 30–39, 40–49, and 50+) among men and women. (B)
Mean age at starting cigarette/bidi smoking by age groups among men
and women.
doi:10.1371/journal.pone.0058516.g001
Table 1. Prevalence of ever cigarette/bidi smoking by
baseline characteristics.a
Men Women
No. (%) P Valueb No. (%) P Valueb
Education (years)
No 2622 (80.5) ,0.001 585 (10.7) ,0.001
1–5 1790 (69.0) 94 (2.7)
6–9 722 (63.5) 5 (0.3)
$10 689 (59.1) 2 (0.2)
Religion
Muslim 5532 (71.2) 0.04 675 (6.0) ,0.001
Hindu/Other 297 (76.0) 11 (2.0)
Body mass index
(kg/m2)
,18.5 2883 (80.1) 421 (10.0) ,0.001
18.5–24.9 2633 (65.7) 240 (3.7)
.24.9 218 (50.2) 18 (1.9)
Hookah smoking
Never 1949 (60.6) ,0.001 247 (3.8) ,0.001
Ever 1803 (99.1) 168 (90.8)
Betel quid chewing
Never 3076 (61.4) ,0.001 126 (1.6) ,0.001
Past 255 (88.5) 31 (17.5)
Current 2486 (87.2) 529 (14.4)
Systolic blood pressure
,140 5263 (71.5) 0.29 589 (5.5) ,0.001
$140 471 (69.6) 91 (9.0)
Diastolic blood pressure
,90 5345 (72.2) ,0.001 609 (5.8) 0.97
$90 388 (61.1) 70 (5.8)
History of diabetes
Yes 110 (66.3) 0.16 7 (4.0) 0.30
No 5567 (71.3) 668 (5.8)
aData were missing on cigarette/bidis smoking for 8 subjects; on education for
11 subjects; on religion for 1 subject; on body mass index for 281 subjects; on
hookah smoking for 8295 subjects; on betel quid chewing for 34 subjects; on
systolic blood pressure for 260 subjects; on diastolic blood pressure for 268
subjects; and on history of diabetes for 321 subjects.
bP-value from the chi-square test or t-test.
doi:10.1371/journal.pone.0058516.t001
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more than 10 pack-years were 1.4–1.8 times more likely to die
from all-cause and 3.3–4.2 times more likely to die from cancer.
Similar but much weaker associations were observed of hookah
smoking with all-cause and cancer mortality. On the other hand,
there was no apparent association between either cigarette/bidi or
hookah smoking and mortality from overall CVD. In women,
there was an increased risk of all-cause mortality among ever (HR
1.65, 1.16 2.36) and past cigarette/bidi smokers (HR 1.92, 1.21
3.05), as well as among ever hookah smokers (HR 2.81, 1.78 4.43).
The number of deaths from cancer in women, however, was not
enough for us to evaluate the association between tobacco smoking
and cancer mortality. The effect estimates for cigarette/bidi and
hookah smoking were in general similar although somewhat
weaker after mutual adjustment. For instance, the HR for the risk
of death from cancer in relation to ever cigarette/bidi smoking
changed from 1.70 (95% CI 1.00 2.91) to 1.58 (95% CI 0.84 2.96)
in overall and from 2.91 (95% CI 1.24 6.80) to 2.54 (95% CI 1.06
6.12) in men, after adjustment for hookah smoking. The HR for
cancer deaths associated with ever hookah smoking changed from
1.38 (95% CI 0.86 2.22) to 1.21 (95% CI 0.74 1.99) in overall and
from 1.30 (95% CI 0.78 2.18) to 1.07 (95% CI 0.63 1.80) in men,
after adjustment for cigarette/bidi smoking. Figure 2 shows the
survival curves for overall survival by cigarette/bidi smoking status
among men and women. The probability of survival was
significantly lower for ever cigarette/bidi smokers than for never
smokers in both men and women.
Further analyses on subtypes of CVD showed that there was an
increased risk of death from IHD among both ever (HR 1.68, 0.94
2.99) and current cigarette/bidi smokers (HR 1.94, 1.08 3.49) in
men, with a stronger association for current smokers (Table 3). In
addition, ever smokers who had smoked for more than 30 years, or
had accumulated more than 30 pack-years were 2.0–2.1 times
more likely to die from IHD. Ever hookah smokers with higher
daily intensity (.5 times/day) were 1.96 (95% CI 1.05 3.63) times
more likely to die from IHD than never smokers. In women, ever
cigarette/bidi smoking was related to a non-significant increase in
risk of IHD was (HR 2.55, 0.86 7.57).
The proportion of all-cause deaths attributable to ever
cigarette/bidi smoking was 25.0% in men and 7.6% in women
(Table 4). The PAF was 4.1%, 12.0%, and 12.3% for light,
moderate, and heavy cigarette/bidi smokers. Ever hookah
smoking was a cause of 7.5% and 8.9% of all-cause deaths in
men and women, respectively.
In men, the HR for all-cause mortality among current
cigarette/bidi smokers who started smoking at age 18 years or
younger were 1.64 (1.21 2.22), 43% higher than that among those
starting at or after 18 years (HR 1.15, 0.84 1.58, Table 5).
Similarly, earlier starting age of smoking was associated with a
greater risk of mortality due to cancer and IHD, and the
association was stronger compared to that for all-cause mortality.
For mortality from all-cause and cancer, while the risk was
reduced 5 years after quitting smoking compared with continuing
to smoke, there was a non-significant increase in risk within 5 years
of quitting smoking. For IHD mortality, there was a significant
downward trend with increasing years since quitting, with a
significant 58% reduction in the risk after 5 or more years since
quitting smoking compared with continued smoking (HR 0.42,
0.19 0.94).
Discussion
In the present study, we found that cigarette/bidi or hookah
smoking was significantly associated with an increased risk of
death from all-cause, cancer, and IHD. There was a highly
significant trend of increasing all-cause and cancer mortality with
increasing cigarette/bidi consumption. The deaths attributable to
cigarette/bidi smoking were much greater in men than in women,
with cigarette/bidi smoking accounting for 25.0% of overall
Figure 2. Survival curves for overall survival by never and ever cigarette/bidi smoking. (A) Overall survival among men. (B) Overall
survival among women. Cox proportional hazards regression analyses were adjusted for baseline age (years), body mass index, and educational
attainment (years).
doi:10.1371/journal.pone.0058516.g002
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mortality in men and 7.6% in women. Significantly increased risk
associated with earlier age at initiation of cigarette/bidi smoking
was observed for all-cause, cancer, and IHD mortality. The excess
risk reduced to the level of never smokers after 5 years or more of
quitting smoking for IHD mortality but not for cancer mortality.
To the best of our knowledge, the present study is the first
prospective study that reports a positive association between
cigarette/bidi smoking and IHD mortality in South Asians, and
Table 3. Association between smoking and mortality from IHD and stroke.
Person years IHD Stroke
No. of
deaths
Hazard ratio (95% confidence





Nonsmokersb 17294 15 1.00 14 1.00
Ever smokers 45125 86 1.68 (0.94–2.99) 79 0.91 (0.50–1.64)
Past smokers 7157 17 1.03 (0.49–2.18) 18 0.70 (0.34–1.44)
Current smokers 37969 69 1.94 (1.08–3.49) 61 1.01 (0.55–1.86)
Number of cigarette smoked per dayc
1–10 26017 47 1.65 (0.90–3.05) 44 0.92 (0.49–1.72)
11–20 12770 26 1.75 (0.90–3.40) 19 0.79 (0.39–1.60)
21–125 6290 13 1.64 (0.76–3.55) 16 1.10 (0.53–2.29)
P for trend 0.20 0.93
Years of smokingc
1–20 17961 16 1.18 (0.57–2.46) 14 0.83 (0.39–1.76)
21–30 11907 26 1.71 (0.87–3.35) 20 1.04 (0.52–2.07)
31–60 7753 33 2.13 (1.06–4.29) 44 1.06 (0.56–2.03)
P for trend 0.02 0.62
Pack–yearsc
1–10 17050 21 1.37 (0.69–2.73) 26 1.16 (0.60–2.26)
11–30 10495 21 1.51 (0.74–3.06) 23 0.98 (0.49–1.94)
31–238 10029 33 1.99 (1.03–3.85) 29 0.89 (0.46–1.72)
P for trend 0.04 0.48
Hookah smoking
Nonsmokersd 31988 41 1.00 38 1.00
Ever smokers 17280 43 1.45 (0.86–2.43) 53 0.91 (0.56–1.46)
Times smoked per dayc
#5 11920 19 1.18 (0.64–2.16) 27 0.90 (0.53–1.53)
.5 7050 24 1.96 (1.05–3.63) 26 0.92 (0.52–1.64)
P for trend 0.04 0.77
Years of smokingc
#5 9735 21 1.74 (0.98–3.10) 14 0.70 (0.37–1.32)
.5 9181 22 1.19 (0.63–2.25) 39 1.07 (0.63–1.81)
P for trend 0.47 0.76
Time–yearsc
#30 10494 21 1.63 (0.92–2.88) 20 0.90 (0.51–1.58)
.30 8412 22 1.28 (0.67–2.44) 33 0.92 (0.53–1.60)
P for trend 0.36 0.77
Women
Cigarette/bidis smoking
Nonsmokersb 17294 11 1.00 30 1.00
Ever smokers 45125 6 2.55 (0.86–7.57) 6 0.98 (0.39–2.46)
aAdjusted for baseline age (years), body mass index, and educational attainment.
bNon-cigarette/bidi smokers as the reference group.
cCategories in ever smokers were based on meaningful cut points for easy interpretation.
dNon-hookah smokers as the reference group.
doi:10.1371/journal.pone.0058516.t003
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the first that reports a benefit of quitting smoking on IHD
mortality.
The positive association between tobacco smoking and all-cause
mortality among both men and women is clearly demonstrated in
Western and Asian populations [20–26]. Previous studies in India
have also provided evidence of excess all-cause mortality
associated with smoking, with relative risks ranging from 1.3 to
2.1 [27–31] and a significant dose–response relationship for
frequency and duration [27–29,31] observed in men. Smoking in
women is relatively uncommon in India, however, similar relative
risk ranging from 1.3 to 2.0 was reported [27,28,31]. We also
found a higher risk among smokers in comparison with never users
for all-cause mortality, with the HR comparable to those
previously reported in Indians. Our lower risks associated with
smoking than those reported from Western populations might be
due to the lower intensity of cigarette/bidi smoking in the past
(mean 12 sticks/day), the older age of smoking initiation (mean 20
years) compared with Western smokers [32], or different
distribution of risk factors that may interact with the effect of
smoking. The risk of all-cause mortality was also higher for hookah
users compared to non-users. It has been reported that water pipe
smoking delivers the addictive drug nicotine and is at least as toxic
as cigarette smoke [33], and hookah smokers are at risk for the
same categories of diseases associated with cigarette smoking [34].
Although the prevalence of hookah smoking has reduced over the
years, our data suggested that the use was more common in
women and hookah smoking accounted for more deaths than
cigarette/bidi smoking did in women.
Cohort studies consistently support an increased risk of cancer
mortality associated with tobacco smoking [25,26,29]. Our overall
HR of 1.7 for ever smokers was similar to estimates from studies
conducted in India, which reported HRs of 1.6–2.0 [29,35,36].
We found that current hookah smokers were 2.5 times more likely
to die from cancer among men. The literature on the effects of
hookah smoking on cancer is limited. Given that most of hookah
smokers (99.1%) are also cigarette/bidi smokers in our study
population, it is difficult to isolate the effects of hookah smoking
from that of cigarette/bidi smoking. We also have a limited sample
size to evaluate cancer specific mortality. Further larger studies on
the associations between hookah smoking and risk of cause-specific
cancer mortality are warranted.
Current cigarette/bidi smoking was significantly associated with
an increased risk of IHD mortality among men, a finding
consistent with previous reports from Japan [37], Korea [38],
and Singapore [25]. A cohort study from India reported a RR of
1.17 (0.99 1.39) for IHD associated with smoking in men [28],
which was much lower than the HR of 1.68 from our study (0.94
2.99). Retrospective and case-control studies from India, however,
reported significant associations between ever smoking and
mortality from heart disease and other vascular disease with
RRs ranging from 1.6–1.8 [30,31]. On the other hand, there was
no apparent association between tobacco smoking and stroke
mortality, consistent with many, [25,37,39] but not all,
[30,31,40,41] previous studies from Asia including India. The
effects of smoking on stroke have been inconsistent by stroke
subtypes. For instance, the association between smoking and
subarachnoid hemorrhage is stronger compared with other types
of stroke [40,42,43] while most of the previous studies did not
show excess mortality from subtypes of ischemic stroke such as
embolic brain infarction among smokers [44,45]. Further studies
are warranted to elucidate the association between smoking and
stroke subtypes in South Asians.
If the associations we observed in our study were largely or
wholly causal then about 25.0% of the deaths in men and 7.6% of
deaths in women were due to cigarette/bidi smoking, consistent
with findings from Singapore (22.6% for men and 5.3% for
women) [25], China (21% for men) [26], and Japan (22% for men
and 5% for women). Interestingly, the proportion of all-cause
deaths in men attributable to smoking in our study population has
reached the level seen in the United States in 2004 [46]. Although
there is evidence from prospective studies regarding the benefits of
smoking cessation, in terms of decreased risk of mortality from all-
cause, cancer and CVD [21,25,42,47–52], the magnitude of the
gain and the time required to prove results are still debatable. In
the present study, a significant reduction in the risk of death from
IHD was observed for smokers who have quitted smoking for
more than 5 years, a finding supported by studies from other Asian
populations [40,49,53,54]. The rapid decline of IHD mortality
following smoking cessation has been documented in the Western
studies [42,51,52]. Within days or weeks, past smokers may
experience the benefits of quitting such as increase in platelet
activation and change in fibrinolytic system [42]. However,
carcinogenic transformation of individual cells and the metastatic
growth of the cancer cells are a long process, and reversal of
cancer risk will likely to take longer time before full benefits can be
observed [42]. In low-income countries such as Bangladesh, the
Table 4. Population attributable fraction for all-cause mortality by smoking.
Proportion of deaths (%) Population attributable fraction
% 95% confidence interval
Men
Ever cigarette/bidi smoking 87.6 25.0 3.8–40.5
Smoking intensity (pack-years)
1–10 23.4 4.1 22.3–9.4
11–30 29.2 12.0 4.1–16.7
31–238 34.0 12.3 3.2–18.1
Ever hookah smoking 57.3 7.5 23.5–17.2
Women
Ever cigarette/bidi smoking 19.4 7.6 1.9–11.2
Ever hookah smoking 13.8 8.9 3.8–10.7
doi:10.1371/journal.pone.0058516.t004
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populations are undergoing an epidemiologic transition in which
the burden of heart disease is increasing. In addition, environ-
mental risk factors such as air pollution and arsenic exposure that
may have synergistic effect on heart disease mortality [12] are
more common. Therefore, the promotion of smoking cessation is
critically important in these populations.
The strengths of the present study include a population-based
prospective design with a high participation rate (97%) at baseline
recruitment, the large sample size, and extensive data on tobacco
smoking and potential confounding factors collected with the use
of in-person interviews at baseline. Although we restricted to
married individuals, Bangladesh has the second-highest rate of
early marriage [55], and most of the adults are married in rural
area. Therefore, we do not believe that the restriction would limit
the generalizability of the study. Several potential limitations,
however, should also be noted. First, the prevalence of tobacco
smoking was very low among women (,10%) compared with men
and precluded us from more detailed analyses in women. Second,
we did not have data on smokeless tobacco use, a popular habit
throughout the world, especially in South and Southeast Asia.
According to a 2009 survey, 26% of adult men and 28% of women
currently use smokeless tobacco and the proportion of current
tobacco users who used both smokeless and smoking tobacco is
22% among men and 3% among women in Bangladesh [56].
Smokeless tobacco use has been shown to increase mortality from
all-cause [27,28], cancer [36], and IHD [57]. To the extent that
the use of smokeless tobacco products is positively related to
smoking and mortality, the association between smoking and
mortality may be overestimated. We were also unable to examine
exposure to environmental tobacco smoke, which has been
causally related to a variety of health effects such as lung cancer,
ischemic heart disease, respiratory effects and other diseases in
adults [58]. Mortality attributable to environmental tobacco
smoke has also been assessed in several populations, although
the results are not entirely consistent [59–63]. To the extent that
nonsmokers may be exposed to environmental tobacco smoke
[58], the association between smoking and mortality may be
underestimated. Third, we did not assess the effect of cigarette and
bidi smoking on mortality separately. However, bidi smoking has
been shown to associate with similar or higher risks of all-cause
and cancer mortality compared with cigarette smoking [27,28,36]
and a bidi delivers a comparable or higher amount of tar and
nicotine although a bidi contains a much smaller amount of
tobacco (,0.2 g) than a cigarette (,1 g) [64].
Conclusion
Tobacco smoking was associated with increased risks of
premature death from all-cause, cancer, and IHD among both
men and women in this Bangladeshi population. Substantial
proportion of death, especially for men, was attributable to
tobacco smoking. Stringent tobacco-control measures and smok-
ing-cessation strategies are needed in Bangladesh as well as other
developing countries with a similar setting.
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